Phase 3 clinical trials of MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) are currently underway in the USA, Canada, and Israel.
These trials, led by the Multidisciplinary Association for Psychedelic Studies (MAPS), are the last step in figuring out if this treatment is safe and effective enough for MDMA to be legally prescribed to treat PTSD.
If there’s a positive result from the trials, this could happen in the USA as soon as 2022.
The Montauk Monster is a pit bull, a dogfighting washout who washed up a Long Island beach. You heard it here first.
Or maybe you heard it elsewhere first. Even with Google Alert, it’s not easy to keep track of the rumors, speculation and rare pieces of actual news concerning the odd-looking corpse found in late July on a beach near Montauk, New York.
First described on pop culture rag Gawker under the apotheosis-of-hipster subheading “Good Luck With Your Hell Demons,” the Montauk Monster hit the internet like a match tossed on lighter fluid. Was it the handiwork of mad government scientists at the nearby Plum Island Animal Disease Center? A member of some miraculously undiscovered species, giving silent testimony to the power of Nature, so exhaustively explored and encroached upon, to surprise?
Nov 11 (Reuters) — Companies in North America added a record number of robots in the first nine months of this year as they rushed to speed up assembly lines and struggled to add human workers.
Factories and other industrial users ordered 29,000 robots, 37% more than during the same period last year, valued at $1.48 billion, according to data compiled by the industry group the Association for Advancing Automation. That surpassed the previous peak set in the same time period in 2017, before the global pandemic upended economies.
The rush to add robots is part of a larger upswing in investment as companies seek to keep up with strong demand, which in some cases has contributed to shortages of key goods. At the same time, many firms have struggled to lure back workers displaced by the pandemic and view robots as an alternative to adding human muscle on their assembly lines.
Forget all the nanotechnology devoted to fighting cancer, and just consider that nanoparticles have invaded makeup, anti-odor socks, sunscreen, plastic beer bottles and home pregnancy tests. Now scientists have developed a way to assess the health and environmental impact of such nanoparticles: a tiny microresonator that can detect and measure individual particles smaller than a single virus.
The microresonator is a lab-on-a-chip that harnesses the “whispering gallery” concept that’s displayed by buildings such as St. Paul’s Cathedral in London. The cathedral’s domed gallery can carry whispers easily across to the other side, but normal-volume voices end up garbled after bouncing around the dome multiple times.
Similarly, microresonators can bounce laser light many times around a circular “waveguide,” such as a glass ring. A laser frequency must perfectly fit the circumference of a ring to achieve this whispering-gallery mode.
A new treatment successfully restored the ability to walk in a group of lab mice with spinal cord injuries! And it took only four weeks.
Researchers in Japan say they have started a clinical trial of ovarian cancer treatment involving immune cells created from induced pluripotent stem cells, or iPS cells.
The team of researchers from the National Cancer Center Hospital East and Kyoto University’s Center for iPS Cell Research and Application made the announcement in an online news conference on Thursday.
The iPS cells used in the treatment are capable of developing into any kind of cell. A gene that reacts strongly to a protein unique to a certain type of ovarian cancer is inserted into iPS cells to create natural killer cells. These NK cells will then be injected into the ovaries of patients with this type of ovarian cancer.
Elon Musk’s revolutionary company Neuralink plans to insert Computer Chips into peoples brains but what if there’s a safer and even more performant way of merging humans and machines in the future?
Enter DARPAs plan to help the emergence of non-invasive brain computer interfaces which led to the organization Battelle to create a kind of Neural Dust to interface with our brains that might be the first step to having Nanobots inside of the human body in the future.
How will Neuralink deal with that potential rival with this cutting edge technology? Its possibilities in Fulldive Virtual Reality Games, Medical Applications, merging humans with artificial intelligence and its potential to scale all around the world are enormous.
If you enjoyed this video, please consider rating this video and subscribing to our channel for more frequent uploads. Thank you! smile
–
#neuralink #ai #elonmusk.
–
Credits:
https://www.youtube.com/watch?v=PhzDIABahyc.
https://www.bensound.com/
Innovation At The Intersection Of Cancer & Aging, Via Digital Health & Behavioral Sciences — Dr. Corinne Leach, Ph.D. American Cancer Society
Dr. Corinne Leach, PhD, MPH, MS, is a gerontologist, digital health strategist, and behavioral scientist, who serves as the Senior Principal Scientist, Behavioral Research, at the American Cancer Society (https://www.cancer.org/).
Dr. Leach, leads survivorship research on behalf of the Population Sciences group, serving as the Principal Investigator of the American Cancer Society (ACS) survivorship cohorts, and as the ACS-lead for the ACS-National Cancer Institute online self-management platform, Springboard Beyond Cancer, a novel eHealth tool that empowers cancer survivors to better manage their cancer-related symptoms, live healthier, and improve their communication skills about cancer (as well as other health conditions), during and after treatment.
Dr. Leach’s cancer survivorship research focuses in the areas of aging, cancer-related symptom assessment, and chronic disease self-management, and her research aims to improve the understanding of: behavioral factors that contribute to healthy aging and the best way to promote them, the unique experiences of older cancer survivors, such as physical late effects and psychosocial issues, and ways to improve survivors’ self-management of cancer-related issues.
Dr. Leach also studies accelerated aging after a cancer diagnosis, including the accumulation of multiple chronic conditions after a cancer diagnosis, and she evaluates the benefits of health behavior interventions, such as chronic disease self-management.
